×

Get the Free Prostate Cancer Patient Guide. Enter your email to get the pdf.

Please leave this field empty

LOS ANGELES, Calif., August 28, 2018 – The Prostate Cancer Foundation (PCF) announced today that it has granted a total of $6 million to 29 promising early career scientists dedicated to advancing critical research in developing better early detection methods, improving life-saving treatments and finding a cure for prostate cancer. Sponsored by the PCF, the Young Investigator Awards program provides both financial support and a comprehensive career development program to early career scientists with unique approaches and groundbreaking ideas to drive the critical research needed to defeat prostate cancer, a disease that nearly 14 million men worldwide are currently battling.

“We are honored to invest in new cutting-edge ideas for prostate cancer research.  This year’s recipients show great potential for unlocking new discoveries and achieving unprecedented strides toward research leading the way to help countless men affected by the disease,” said Jonathan Simons, MD, PCF’s President and CEO.

As a nonprofit organization committed to globally accelerating the development of new breakthroughs in prostate cancer, the PCF has invested more than $53 million to support 255 young investigators since 2007. The 2018 Young Investigator Awards recipients were selected from a pool of 103 applications from 55 institutions in 11 countries.

Recipients of the PCF Young Investigator Award must demonstrate significant promise for having a long-term and impactful career in the prostate cancer research field. Awardees must be within six years of completing professional scientific training programs and be under the guidance of at least one mentor.  Eleven of the 2018 PCF Young Investigator Awardees are conducting research to improve prostate cancer outcomes in U.S. Veterans.   Additional research focus areas include: novel precision medicine; new treatments and treatment strategies; immunotherapy; studying inherited genetic alterations for those at increased risk; and prostate cancer disparities particularly among African-American men.

 

The 2018 Young Investigator Awards recipients are:

Name Institution Donor(s)
Saud AlDubayan, MD Harvard: Dana-Farber Cancer Institute Paz Littman and Morris Kahn
Mohammad Asim, PhD University of Surrey, United Kingdom Clovis Oncology, Inc.
Hala Borno, MD University of California, San Francisco Lenny Sands
Frank Cackowski, MD, PhD University of Michigan Jay Jordan
Megan Caram, MD University of Michigan Tony D. Minella
Kellie Cotter, PhD University of Bern, Switzerland Todd Boehly
Anis Hamid, MBBS Harvard: Dana-Farber Cancer Institute Jeremy Coller
Jennifer Jones, MD, PhD National Cancer Institute National Cancer Institute
Salma Kaochar, PhD Baylor College of Medicine John and Daria Barry Foundation
Sheng-Yu Ku, PhD Weill Cornell Medicine Michael and Lori Milken Family Foundation
Hui Li, PhD University of California, San Francisco John and Daria Barry Foundation
Brandon Mahal, MD Harvard: Dana-Farber Cancer Institute American Society for Radiation Oncology
Danil Makarov, MD New York University Thomas H. Lee
Megan McNamara, MD Duke University Thomas Finke
Kent Mouw, MD, PhD Harvard: Dana-Farber Cancer Institute Rebecca and Nathan Milikowsky
Vivek Narayan, MD University of Pennsylvania, Abramson Cancer Center James Maguire
David Oh, MD, PhD University of California, San Francisco John and Daria Barry Foundation
Eileen Parkes, MD, PhD Queen’s University Belfast, Northern Ireland Foundation 14
Raquel Perez-Lopez, MD, PhD Vall d’Hebron Institute of Oncology, Spain Gina Rinehart
Sethuramasundaram Pitchiaya, PhD University of Michigan Keith Frankel, Michael DeAddio, and Thomas H. Lee
Nicholas Reder, MD, MPH University of Washington Seth Bernstein
Zachery Reichert, MD, PhD University of Michigan Igor Tulchinsky
Veronica Rodriguez-Bravo, PhD Thomas Jefferson University, Sidney Kimmel Cancer Center Clay Hamlin in honor of H. Ward Hamlin Jr.
Joshua Russo, MD, PhD Harvard: Beth Israel Deaconess Medical Center Michael and Lori Milken Family Foundation
Adam Sharp, MD, PhD Institute of Cancer Research, London, United Kingdom Larry Ruvo
Min Yuen Teo, MD Memorial Sloan Kettering Cancer Center Michael and Lori Milken Family Foundation in Honor of Selma Rabin
Vasanthi Viswanathan, PhD Harvard: Broad Institute of MIT & Harvard Seth Bernstein
Scott Wilkinson, PhD National Cancer Institute National Cancer Institute
David Wise, MD, PhD New York University John and Daria Barry Foundation

 

For more information about the 2018 Young Investigator Awards recipients, visit pcf.org/c/young-investigator-award-class-of-2018/.

About the Prostate Cancer Foundation (PCF): PCF is the world’s leading philanthropic organization funding and accelerating prostate cancer research. Founded in 1993, PCF has raised more than $765 million and provided funding to more than 2,000 research programs at nearly 210 cancer centers and universities. The PCF global research enterprise now extends to 22 countries. PCF advocates for greater awareness of prostate cancer and more efficient investment of governmental research funds for transformational cancer research. Its efforts have helped produce a 20-fold increase in government funding for prostate cancer. For more information, visit www.pcf.org.

 

#   #   #

MEDIA CONTACT:

Colleen McKenna
Prostate Cancer Foundation
(310) 570-4722
cmckenna@pcf.org

 

Donald Wilson
(310) 428-4730
dwilson.dwpr@gmail.com